Literature DB >> 15605185

Invasive meningococcal disease presenting as Henoch-Schonlein purpura.

M N Tsolia1, A Fretzayas, H Georgouli, G Tzanakaki, S Fessatou, G Liapi-Adamidou, A Constantopoulos.   

Abstract

Henoch-Schonlein purpura (HSP) is an acute systemic form of vasculitis that has been associated with a number of viral and bacterial infections. Described here are the cases of two children with invasive meningococcal disease who presented with clinical and laboratory findings typical of HSP. Meningococcal infection may have been the trigger for the manifestation of HSP in these patients.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15605185     DOI： 10.1007/s10096-004-1203-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


  16 in total

1.  Henoch-Schönlein purpura following meningitis C vaccination.

Authors:  P A Courtney; R N Patterson; R J Lee
Journal:  Rheumatology (Oxford)       Date:  2001-03       Impact factor: 7.580

Review 2.  Henoch-Schönlein purpura.

Authors:  F T Saulsbury
Journal:  Curr Opin Rheumatol       Date:  2001-01       Impact factor: 5.006

Review 3.  Intravenous immunoglobulin therapy for severe digestive manifestations of Henoch-Schönlein purpura.

Authors:  T Lamireau; L Rebouissoux; J P Hehunstre
Journal:  Acta Paediatr       Date:  2001-09       Impact factor: 2.299

4.  Rash resembling anaphylactoid purpura as the initial manifestation of meningococcemia.

Authors:  H Rosenberg; R Bortolussi; J G Gatien
Journal:  Can Med Assoc J       Date:  1981-07-15       Impact factor: 8.262

5.  Meningococcal disease among children who live in a large metropolitan area, 1981-1996.

Authors:  V J Wang; N Kuppermann; R Malley; E D Barnett; H C Meissner; E V Schmidt; G R Fleisher
Journal:  Clin Infect Dis       Date:  2001-03-15       Impact factor: 9.079

6.  Bacterial infection presenting as cutaneous vasculitis in adults.

Authors:  C García-Porrúa; M A González-Gay
Journal:  Clin Exp Rheumatol       Date:  1999 Jul-Aug       Impact factor: 4.473

7.  Improved case confirmation in meningococcal disease with whole blood Taqman PCR.

Authors:  S J Hackett; E D Carrol; M Guiver; J Marsh; J A Sills; A P J Thomson; E B Kaczmarski; C A Hart
Journal:  Arch Dis Child       Date:  2002-06       Impact factor: 3.791

8.  Evaluation of non-culture diagnosis of invasive meningococcal disease by polymerase chain reaction (PCR).

Authors:  Georgina Tzanakaki; Maria Tsolia; Vasiliki Vlachou; Maria Theodoridou; Anastasia Pangalis; Maria Foustoukou; Themistocles Karpathios; C Caroline Blackwell; Jenny Kremastinou
Journal:  FEMS Immunol Med Microbiol       Date:  2003-10-24

9.  The evolving epidemiology of invasive meningococcal disease: a two-year prospective, population-based study in children in the area of Athens.

Authors:  Maria N Tsolia; Maria Theodoridou; Georgina Tzanakaki; Panayotis Kalabalikis; Evangelia Urani; Glykeria Mostrou; Anastasia Pangalis; Anthi Zafiropoulou; Corina Kassiou; Dimitris A Kafetzis; C Caroline Blackwell; Jenny Kremastinou; Th E Karpathios
Journal:  FEMS Immunol Med Microbiol       Date:  2003-05-15

10.  Allergic complications of meningococcal disease. II. Immunological investigations.

Authors:  B M Greenwood; H C Whittle; A D Bryceson
Journal:  Br Med J       Date:  1973-06-30
View more
  1 in total

1.  Immune complex reaction after successful treatment of meningococcal disease: an excellent response to IVIG.

Authors:  Rashna Dass; Himesh Barman; Saurabh Gohain Duwarah; Nayan Mani Deka; Pankaj Jain; Vivek Choudhury
Journal:  Rheumatol Int       Date:  2010-07-24       Impact factor: 2.631
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.